PubMed RSS Feed - -[Time to limit the use of antibiotics in rosacea!]

[rss]

Related Articles

[Time to limit the use of antibiotics in rosacea!]

Lakartidningen. 2018 Apr 24;115:

Authors: Mobacken H, Berg M, Angesjö E, Dunér K, Svensson M, Synnerstad I

Abstract
Rosacea is a chronic inflammatory disease with facial erythema and papulopustules. It is common in middle-aged/elderly persons and often affects self-perception and social well-being. It is generally classified into four subtypes. Improved understanding of pathophysiology has resulted in novel treatment approaches, but routine management in health care usually follows old trails. Most patients are managed in primary care. Greater attention to the reduced skin barrier, avoidance of exacerbating factors, better topicals and encouragement to topical maintenance treatment should reduce the use of oral tetracyclines. Low-dose isotretinoin is reserved for treatment-resistant patients, but relapses are frequent unlike its use in acne. In order to reduce antibiotic use, we propose that patients should be referred to a dermatologist for optimization of therapy including consideration of isotretinoin following tetracycline treatment of a maximum of 4-6 months.

PMID: 29714807 [PubMed - in process]

{url} = URL to article